Please provide your email address to receive an email when new articles are posted on . Thrombophilia is a known risk factor for venous thromboembolism, but the value of thrombophilia testing in ...
Please provide your email address to receive an email when new articles are posted on . ASH panel recommends thrombophilia testing for multiple patient populations. Indefinite anticoagulant treatment ...
(WASHINGTON, April 30, 2004) – Enoxaparin, an anticoagulant, has proven to be an effective preventive measure against stillbirth in pregnant women with hereditary thrombophilia, according to a new ...
Common heritable thrombophilias include factor V Leiden (1 in 20 white Europeans are heterozygous) and prothrombin G20210A (1 in 50 white Europeans are heterozygous), and uncommon ones include protein ...
(San Diego, Calif., December 6, 2003) – Several studies presented during the 45th Annual Meeting of the American Society of Hematology shed light on some promising new therapies that are in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results